05.17.10
David Spaight has been appointed chief executive officer of WIL Research Company. He will also join the board of directors. Mr. Spaight will oversee the company’s four major businesses: WIL Research Labs, NOTOX, Midwest BioResearch and QS Pharma. He will continue to implement a long-term strategy of integrating the businesses to provide greater value and full service to clients across the globe.
Mr. Spaight has more than 25 years of experience in the life and analytical sciences industry, as well as experience in business integration, operational improvement and client relationship development. Most recently, he served as president of MDS Pharma Services, where he managed a team of more than 3,500 professionals across 35 sites in 27 countries. During his tenure at MDS, he served on the board of directors for the Association of Clinical Research Organizations (ACRO) and was named chairman for 2008.
“Pharma companies around the world are looking for specific expertise in key areas of drug discovery and development,” said Mr. Spaight. “The scientific expertise of our staff is unmatched and provides a strong base for future growth. I look forward to strengthening this organization as we continue to deliver exceptional value to our clients.”
Mr. Spaight has more than 25 years of experience in the life and analytical sciences industry, as well as experience in business integration, operational improvement and client relationship development. Most recently, he served as president of MDS Pharma Services, where he managed a team of more than 3,500 professionals across 35 sites in 27 countries. During his tenure at MDS, he served on the board of directors for the Association of Clinical Research Organizations (ACRO) and was named chairman for 2008.
“Pharma companies around the world are looking for specific expertise in key areas of drug discovery and development,” said Mr. Spaight. “The scientific expertise of our staff is unmatched and provides a strong base for future growth. I look forward to strengthening this organization as we continue to deliver exceptional value to our clients.”